Stock Market News 6 October 2025

AI Ignites a Nuclear Renaissance: How Tech Titans, Policy Shifts and New Reactors Are Powering the Next Energy Revolution

Nano Nuclear’s Stock Explodes: Could Micro‑Reactors Spark a New Energy Revolution? – NNE Company Report (Oct 2025)

Key Facts (as of 6 Oct 2025) Company Overview Nano Nuclear Energy Inc., headquartered in New York City, describes itself as an advanced nuclear energy and technology company working to build clean, resilient power systems. The firm is developing modular micro‑reactors designed to provide

6 October 2025

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock Soars After Trump’s Drug Deal and Obesity Bet – Is This the Start of a Comeback?

Stock Performance: From Laggard to Late-September Lift For much of 2025, Pfizer’s stock was stuck in a rut – but that changed dramatically as Q4 approached. By late September, PFE had drifted down near multi-year lows around $23, reflecting a

6 October 2025

Business News · Healthcare · Investment Trends · NYSE:LLY · NYSE:NVO · NYSE:PFE · Pharma Industry · Stock Market

Robinhood (HOOD) Explodes 12% to Fresh Highs — Here’s What Lit the Fuse and What Comes Next (Sept 29, 2025)

Robinhood’s Stock Skyrockets 200% – S&P 500 Debut, Crypto Push & Outage Drama in 2025

Stock Performance & Key Market Data (Oct 6, 2025) Robinhood’s stock has been on a remarkable tear in 2025. As of October 6, HOOD traded around $147 per share, not far from its all-time highs beincrypto.com. The stock has nearly

6 October 2025

Cryptocurrency · Financial News · S&P 500 · Stock Market · Tech Industry

AST SpaceMobile Stock Skyrockets on Satellite Breakthroughs and Big-Name Backing

AST SpaceMobile (ASTS) Skyrockets on Satellite Breakthroughs – SpaceX & AT&T Partnerships Fuel Rally

Stock Surge and Recent Performance AST SpaceMobile’s stock skyrocketed in early October 2025, making it one of the market’s top performers. Shares climbed from the high-$40s into the mid-$60s within days on massive trading volumes ts2.tech. In fact, ASTS more

6 October 2025

NASDAQ:ASTS · Satellite Technology · Space Industry · SpaceX News · Stock Market · Telecommunications

Lithium Americas (LAC) Soars as US Govt Takes 5% Stake – Analysts Weigh In on EV Lithium Boom

Lithium Americas (LAC) Soars on U.S. ‘White Gold’ Stake – Latest News, Stock Rally & Expert Outlook

Latest News & Recent Developments (October 2025) U.S. Government Takes a Stake: The headline news propelling Lithium Americas in early October 2025 is the U.S. Department of Energy’s decision to take equity stakes in the company and its flagship project.

6 October 2025

Expert Analysis · Investing · Lithium · News · NYSE:GM · NYSE:LAAC · Stock Market

MicroStrategy (MSTR) on Oct. 2 2025: Why the Bitcoin Treasury King Keeps Making Headlines

MicroStrategy (MSTR) Skyrockets as Bitcoin Breaks $120K – Inside the Bold $70B Bitcoin Bet

MSTR Stock Rallies on Bitcoin’s “Uptober” Boom MicroStrategy’s stock price has been on a tear alongside the latest Bitcoin rally. On October 1, 2025, MSTR leapt about 6% intraday after the U.S. Treasury clarified that unrealized crypto gains will be

6 October 2025

Bitcoin · Cryptocurrency · Financial News · Investments · NASDAQ:MSTR · Stock Market

Marvell Technology (MRVL) Surges on AI Boom – Latest Stock Price, Major News & 2025 Outlook

Stock Price & Recent Performance (Oct 2025) Marvell’s stock has experienced high volatility in 2025, mirroring the boom-bust swings of AI-related stocks. After nearly tripling in 2023 on AI enthusiasm, MRVL hit a record $127.48 in January 2025, then slumped

6 October 2025

AI News · Financial Analysis · Investment Trends · Stock Market · Technology Stocks

Marathon Digital Rides “Uptober” Bitcoin Boom – Stock Soars as Miner Hoards BTC and Eyes Bold 2025 Targets

Bitcoin “Uptober” Powers Marathon’s Stock Surge October 2025 finds Marathon Digital Holdings riding high on a wave of Bitcoin enthusiasm. In the first week of October, Bitcoin’s price blasted past $120,000 – approaching its all-time highs – in what crypto

6 October 2025

Bitcoin · Cryptocurrency · Investment · NASDAQ:MARA · Stock Market · Technology News

IBM Stock Soars on Quantum Breakthrough and AI Revival – Key Updates (Sept 25, 2025)

IBM’s AI Revolution Sends Stock Soaring as Big Blue Takes on Tech Giants

Stock Performance: Riding High into October IBM’s stock has been on a steady upswing and enters October 2025 trading near its highest levels in years. The stock closed at $288.37 on Friday, Oct 3 markets.financialcontent.com, essentially flat to slightly up over

6 October 2025

Artificial Intelligence · Big Tech · IBM · NYSE:IBM · Stock Market · Technology Industry

UiPath’s AI Gold Rush: OpenAI, NVIDIA & Google Deals Ignite PATH’s Stock Rally

UiPath (PATH) Stock Soars on AI Deals and Strong Earnings – 2025 Update

UiPath Inc.’s emphasis on new AI partnerships and products has fueled a stock rally in late 2025. Financial Performance at a Glance (Q2 FY2026) To contextualize UiPath’s recent performance, below is a summary of key financial metrics for the quarter

6 October 2025

2025 Outlook · Artificial Intelligence · Earnings Reports · NYSE:PATH · Stock Market · Technology News

NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia’s AI Juggernaut: What You Need to Know About NVDA After the $100 Billion OpenAI Deal and Its Record Rally (Oct 2025)

Recent News (Late Sept – Oct 6 2025) AMD–OpenAI Partnership Challenges Nvidia’s Dominance Reuters and technology outlets reported on Oct 6 that AMD signed a multi‑year deal to supply hundreds of thousands of AI GPUs (6 GW) to OpenAI. The deal gives OpenAI an option to

6 October 2025

Artificial Intelligence · Business · NASDAQ:NVDA · NVIDIA · Stock Market · Technology

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Rockets on GLP‑1 Boom and New Approvals: Is LLY the Next Trillion‑Dollar Pharma Titan?

In‑Depth Report Introduction Eli Lilly and Company (NYSE: LLY) has become the poster‑child for the emerging class of GLP‑1‑based obesity and diabetes therapies. Its injectable tirzepatide products Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management) have delivered explosive growth, propelling

6 October 2025

Biotech News · GLP‑1 Drugs · Investment Analysis · NYSE:LLY · Pharma Industry · Stock Market